- Chapel Hill NC, US - Denver CO, US Stephen V. FRYE - Chapel Hill NC, US Douglas Kim GRAHAM - Atlanta GA, US
International Classification:
A61K 31/5377 A61K 31/519 A61K 45/06
Abstract:
The present invention is directed to methods of treating a tumor, in particular human tumors, including administering an effective amount of a MER tyrosine kinase inhibitor (MER TKI) to inhibit TKI signaling in a tumor. The use of a MER TKI in combination with a chemotherapeutic agent, wherein the MER TKI can be administered to a host with a cancer prior to, during, or after administration with a chemotherapeutic agent, provides for increased anti-tumor effects without an increase in the standard of care dosage of the chemotherapeutic agent.
Childrens Hospital Center For Cancer & Blood Disorders 13123 E 16 Ave STE B115, Aurora, CO 80045 7207778357 (phone), 7207777231 (fax)
Education:
Medical School University of North Carolina School of Medicine at Chapel Hill Graduated: 1996
Procedures:
Bone Marrow Biopsy Chemotherapy Lumbar Puncture
Conditions:
Anemia Hodgkin's Lymphoma Leukemia Non-Hodgkin's Lymphoma Poisoning by Drugs, Meds, or Biological Substances
Languages:
English Spanish
Description:
Dr. Graham graduated from the University of North Carolina School of Medicine at Chapel Hill in 1996. He works in Aurora, CO and specializes in Pediatric Hematology-Oncology. Dr. Graham is affiliated with Childrens Hospital Colorado.